Bevacizumab Versus Ranibizumab for Diabetic Retinopathy

Clinical trial NCT00545870 · COMPLETED

Trial details

NCT number: NCT00545870
Sponsor: Ursula Schmidt-Erfurth, M.D.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetic Retinopathy Diabetic Macular Edema Proliferative Diabetic Retinopathy

Start date: 2008-06-01
Primary completion: 2013-03-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.